December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NASDAQ:NKGN

Recent news which mentions NASDAQ:NKGN

NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024
Tickers NKGN
Tags Market News NASDAQ:NKGN NKGN
From InvestorPlace
NKGN Stock Earnings: NKGen Biotech Reported Results for Q4 2023
Tickers NKGN
Tags Earnings Reports NKGN NASDAQ:NKGN
From InvestorPlace
Why Is NKGen Biotech (NKGN) Stock Up 62% Today?
Tickers NKGN
Tags NASDAQ:NKGN NKGN Today's Market
From InvestorPlace
Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies
Tickers NKGN
Tags NASDAQ:NKGN
From News Direct
NKGen Biotech Advances Alzheimer's Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial
Tickers NKGN
Tags NASDAQ:NKGN
From News Direct
NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.
Tickers NKGN
Tags NASDAQ:NKGN
From News Direct
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.